DrugPatentWatch Database Preview
Drugs in Development Information for Laquinimod
» See Plans and Pricing
What is the development status for investigational drug Laquinimod?
Laquinimod is an investigational drug.
There have been 15 clinical trials for Laquinimod.
The most recent clinical trial was a Phase 3 trial, which was initiated on December 1st 2007.
The most common disease conditions in clinical trials are Multiple Sclerosis, Sclerosis, and Multiple Sclerosis, Relapsing-Remitting. The leading clinical trial sponsors are Teva Pharmaceutical Industries, Teva Branded Pharmaceutical Products, R&D Inc., and [disabled in preview].
Summary for Laquinimod
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 705 |
| WIPO Patent Applications | 993 |
| Japanese Patent Applications | 1 |
| Clinical Trial Progress | Phase 3 (2007-12-01) |
| Vendors | 91 |
Recent Clinical Trials for Laquinimod
| Title | Sponsor | Phase |
|---|---|---|
| A Phase 2 Clinical Study in Subjects With Primary Progressive Multiple Sclerosis to Assess the Efficacy, Safety and Tolerability of Two Oral Doses of Laquinimod Either of 0.6 mg/Day or 1.5mg/Day (Experimental Drug) as Compared to Placebo | Teva Pharmaceutical Industries | Phase 2 |
| A Clinical Study in Subjects With Huntington's Disease to Assess the Efficacy and Safety of Three Oral Doses of Laquinimod | Teva Branded Pharmaceutical Products, R&D Inc. | Phase 2 |
| A Phase I Study in Young Healthy Women to Investigate the Effects of Laquinimod on Standard Oral Contraceptive When Both Treatments Are Given Together | Teva Pharmaceutical Industries | Phase 1 |
Clinical Trial Summary for Laquinimod
Top disease conditions for Laquinimod
Top clinical trial sponsors for Laquinimod
US Patents for Laquinimod
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
